PUBLISHER: BIS Research | PRODUCT CODE: 1594218
PUBLISHER: BIS Research | PRODUCT CODE: 1594218
Europe Non-Invasive Prenatal Testing (NIPT) Market: Focus on Method, Platform, End User, Application, and Country - Analysis and Forecast, 2023-2033
Introduction to Europe Non-Invasive Prenatal Testing (NIPT) Market
The Europe NIPT market was valued at $859.2 million in 2023 and is expected to reach $3,230.6 million by 2033, registering a CAGR of 14.16% during the forecast period 2023-2033. The European NIPT market is primarily driven by the implementation of favorable guidelines, the inclusion of screening procedures in reimbursement policies, ongoing advancements in technology, expanding commercial opportunities across the region, and the growing preference for non-invasive testing methods.
Market Introduction
| KEY MARKET STATISTICS | |
|---|---|
| Forecast Period | 2023 - 2033 |
| 2023 Evaluation | $859.2 Million |
| 2033 Forecast | $3,230.6 Million |
| CAGR | 14.16% |
The market for non-invasive prenatal testing (NIPT) in Europe has grown significantly in recent years due to the development of genomic technologies and the increased need for prenatal screening techniques that are safer and more accurate. The ground-breaking method known as NIPT looks for chromosomal abnormalities such Patau syndrome, Edwards syndrome, and Down syndrome by analyzing cell-free fetal DNA in the mother's bloodstream. It is a preferred choice for pregnant parents and medical professionals because of its non-invasive nature, which removes the hazards connected to conventional diagnostic techniques like amniocentesis.
Favorable regulatory frameworks, growing patient and healthcare professional knowledge, and the incorporation of NIPT into both public and private healthcare systems all contribute to the market's growth. Its popularity has been further accelerated by reimbursement regulations in a number of European nations, especially in areas with established prenatal care infrastructure.
The market's major players are concentrating on technology advancements to improve the NIPT services' affordability, accessibility, and accuracy. Furthermore, the necessity for trustworthy prenatal screening methods has increased due to the tendency of late pregnancies and the aging of mothers. Consequently, the NIPT market in Europe is expected to increase steadily, contributing to better maternal and fetal healthcare outcomes throughout the area and facilitating informed decision-making.
Market Segmentation:
Segmentation 1: by Application
- Trisomy Detection
- Microdeletion Detection
- Sex Chromosome Aneuploidy Detection
- Others
Segmentation 2: by End User
- Hospitals
- Diagnostic Laboratories
- Others
Segmentation 3: by Platform
- NGS
- PCR
- Others
Segmentation 4: by Method
- cfDNA
- FCMB
Segmentation 5: by Country
- France
- Germany
- Italy
- Spain
- U.K.
- Rest-of-Europe
How can this report add value to an organization?
Workflow/Innovation Strategy: The Europe NIPT market (by application) has been segmented into detailed segments of the application of NIPT based on applications, including trisomy detection, microdeletion detection, sex chromosome aneuploidy detection, and others.
Growth/Marketing Strategy: Constant advancement and innovation to enhance performance and efficiency can enabled prominent players to command premium prices while maintaining growth in revenue and volume.
Competitive Strategy: Key players in the Europe NIPT market have been analyzed and profiled in the study, including manufacturers involved in new product launches, acquisitions, expansions, and strategic collaborations. Moreover, a detailed competitive benchmarking of the players operating in the Europe NIPT market has been done to help the reader understand how players stack against each other, presenting a clear market landscape. Additionally, comprehensive competitive strategies such as partnerships, agreements, and collaborations will aid the reader in understanding the untapped revenue pockets in the market.
Key Market Players and Competition Synopsis
The companies that are profiled have been selected based on thorough secondary research, which includes analyzing company coverage, product portfolio, market penetration, and insights gathered from primary experts.
Some prominent names established in this market are:
- F. Hoffmann-La Roche Ltd
- CENTOGENE N.V.
- Yourgene Health
- Eurofins Scientific SE
Table of Contents
Executive Summary
Scope and Definition
1 Markets
- 1.1 Trends: Current and Future Impact Assessment
- 1.1.1 Increasing Strategic Partnerships and Alliances between Market Players
- 1.1.2 Expanding Applications in NIPT Products
- 1.2 Supply Chain Overview
- 1.3 Research and Development Review
- 1.3.1 Patent Filing Trend (by Country, Year)
- 1.4 Regulatory Landscape
- 1.4.1 Regulatory Scenario in the U.K.
- 1.4.2 Regulatory Scenario in Germany
- 1.4.3 Regulatory Scenario in France
- 1.4.4 Regulatory Scenario in Spain
- 1.4.5 Regulatory Scenario in Italy
- 1.4.6 Regulatory Scenario in the Netherlands
- 1.5 Reimbursement Scenario
- 1.6 Market Dynamics Overview
- 1.6.1 Market Drivers
- 1.6.1.1 High Incidence of Genetic Disorders
- 1.6.1.2 Rising Maternal Age
- 1.6.1.3 Increasing Number of Reimbursement Policies toward Genetic Coverage
- 1.6.1.4 Increased Emphasis on Early Detection and Prevention
- 1.6.2 Market Restraints
- 1.6.2.1 Stringent Regulatory Guidelines and Ethical Hurdles
- 1.6.2.2 Lack of Awareness Regarding NIPT
- 1.6.2.3 Limitations and Considerations in Non-Invasive Prenatal Testing
- 1.6.3 Market Opportunities
- 1.6.3.1 Increasing Focus on Non-Invasive Pre-Implantation Genetic Testing (niPGT)
- 1.6.1 Market Drivers
2 Regions
- 2.1 Drivers and Restraints
- 2.2 Regional Summary
- 2.3 Europe
- 2.3.1 Regional Overview
- 2.3.2 Driving Factors for Market Growth
- 2.3.3 Factors Challenging the Market
- 2.3.4 Application
- 2.3.5 Product
- 2.3.6 France
- 2.3.7 Germany
- 2.3.8 U.K.
- 2.3.9 Spain
- 2.3.10 Italy
- 2.3.11 Rest-of-Europe
3 Markets - Competitive Benchmarking & Company Profiles
- 3.1 Competitive Landscape
- 3.1.1 F. Hoffmann-La Roche Ltd
- 3.1.1.1 Overview
- 3.1.1.2 Product Portfolio
- 3.1.1.3 Top Competitors
- 3.1.1.4 Target Customers
- 3.1.1.5 Key Personnel
- 3.1.1.6 Analyst View
- 3.1.2 CENTOGENE N.V.
- 3.1.2.1 Overview
- 3.1.2.2 Product Portfolio
- 3.1.2.3 Top Competitors
- 3.1.2.4 Target Customers
- 3.1.2.5 Key Personnel
- 3.1.2.6 Analyst View
- 3.1.3 Yourgene Health
- 3.1.3.1 Overview
- 3.1.3.2 Product Portfolio
- 3.1.3.3 Top Competitors
- 3.1.3.4 Target Customers
- 3.1.3.5 Key Personnel
- 3.1.3.6 Analyst View
- 3.1.4 Eurofins Scientific SE
- 3.1.4.1 Overview
- 3.1.4.2 Product Portfolio
- 3.1.4.3 Top Competitors
- 3.1.4.4 Target Customers
- 3.1.4.5 Key Personnel
- 3.1.4.6 Analyst View
- 3.1.1 F. Hoffmann-La Roche Ltd
4 Research Methodology
- 4.1 Data Sources
- 4.1.1 Primary Data Sources
- 4.1.2 Secondary Data Sources
- 4.1.3 Data Triangulation
- 4.2 Market Estimation and Forecast
List of Figures
- Figure 1: Non-Invasive Prenatal Testing Market (by Region), $Million, 2022, 2026, and 2033
- Figure 2: Europe Non-Invasive Prenatal Testing Market (by Application), $Million, 2022, 2026, and 2033
- Figure 3: Europe Non-Invasive Prenatal Testing Market (by End User), $Million, 2022, 2026, and 2033
- Figure 4: Europe Non-Invasive Prenatal Testing Market (by Platform), $Million, 2022, 2026, and 2033
- Figure 5: Europe Non-Invasive Prenatal Testing Market (by Method), $Million, 2022, 2026, and 2033
- Figure 6: Non-Invasive Prenatal Testing Market, Recent Developments, 2023
- Figure 7: Supply Chain of NIPT Market
- Figure 8: NIPT Market, Patent Analysis, (by Country), January 2020-December 2023
- Figure 9: NIPT Market, Patent Analysis, (by Year), January 2020-December 2023
- Figure 10: Reimbursement Scenario in Major Countries of the Europe NIPT Market
- Figure 11: Impact Analysis of Market Navigating Factors, 2022-2033
- Figure 12: Births with Trisomies per 100,000 Live Births in Europe Region, 2000-2021
- Figure 13: Age of Mother at Childbirth over the Years
- Figure 14: Reimbursement Scenario in Major Countries
- Figure 15: Number of Tests Processed by Natera, Inc., 2018-2020
- Figure 16: Positives from Data of 75,000 NIPT Tests Showing False Positives
- Figure 17: Europe Non-Invasive Prenatal Testing Market, Thousand Units, 2023-2033
- Figure 18: Europe Non-Invasive Prenatal Testing Market, $Million, 2023-2033
- Figure 19: France Non-Invasive Prenatal Testing Market, Thousand Units, 2023-2033
- Figure 20: France Non-Invasive Prenatal Testing Market, $Million, 2023-2033
- Figure 21: Germany Non-Invasive Prenatal Testing Market, Thousand Units, 2023-2033
- Figure 22: Germany Non-Invasive Prenatal Testing Market, $Million, 2023-2033
- Figure 23: U.K. Non-Invasive Prenatal Testing Market, Thousand Units, 2023-2033
- Figure 24: U.K. Non-Invasive Prenatal Testing Market, $Million, 2022-2033
- Figure 25: Spain Non-Invasive Prenatal Testing Market, Thousand Units, 2023-2033
- Figure 26: Spain Non-Invasive Prenatal Testing Market, $Million, 2022-2033
- Figure 27: Italy Non-Invasive Prenatal Testing Market, Thousand Units, 2023-2033
- Figure 28: Italy Non-Invasive Prenatal Testing Market, $Million, 2022-2033
- Figure 29: Rest-of-Europe Non-Invasive Prenatal Testing Market, Thousand Units, 2023-2033
- Figure 30: Rest-of-Europe Non-Invasive Prenatal Testing Market, $Million, 2022-2033
- Figure 31: Share of Strategic Initiatives
- Figure 32: Data Triangulation
- Figure 33: Top-Down and Bottom-Up
- Figure 34: Assumptions and Limitations
List of Tables
- Table 1: Market Snapshot
- Table 2: Non-Invasive Prenatal Testing Market, Opportunities
- Table 3: Key Companies' Partnerships and Alliances
- Table 4: NIPT Tests in the NIPT Market and their Corresponding Applications
- Table 5: Risk of Chromosomal Abnormality w.r.t Maternal Age
- Table 6: Non-Invasive Prenatal Testing Market (by Region), Thousands Units, 2022-2033
- Table 7: Non-Invasive Prenatal Testing Market (by Region), $Million, 2022-2033
- Table 8: Europe Non-Invasive Prenatal Testing Market (by Application), $Million, 2022-2033
- Table 9: Europe Non-Invasive Prenatal Testing Market (by End User), $Million, 2022-2033
- Table 10: Europe Non-Invasive Prenatal Testing Market (by Platform), $Million, 2022-2033
- Table 11: Europe Non-Invasive Prenatal Testing Market (by Method), $Million, 2022-2033
- Table 12: France Non-Invasive Prenatal Testing Market (by Application), $Million, 2022-2033
- Table 13: France Non-Invasive Prenatal Testing Market (by End User), $Million, 2022-2033
- Table 14: France Non-Invasive Prenatal Testing Market (by Platform), $Million, 2022-2033
- Table 15: France Non-Invasive Prenatal Testing Market (by Method), $Million, 2022-2033
- Table 16: Germany Non-Invasive Prenatal Testing Market (by Application), $Million, 2022-2033
- Table 17: Germany Non-Invasive Prenatal Testing Market (by End User), $Million, 2022-2033
- Table 18: Germany Non-Invasive Prenatal Testing Market (by Platform), $Million, 2022-2033
- Table 19: Germany Non-Invasive Prenatal Testing Market (by Method), $Million, 2022-2033
- Table 20: U.K. Non-Invasive Prenatal Testing Market (by Application), $Million, 2022-2033
- Table 21: U.K. Non-Invasive Prenatal Testing Market (by End User), $Million, 2022-2033
- Table 22: U.K. Non-Invasive Prenatal Testing Market (by Platform), $Million, 2022-2033
- Table 23: U.K. Non-Invasive Prenatal Testing Market (by Method), $Million, 2022-2033
- Table 24: Spain Non-Invasive Prenatal Testing Market (by Application), $Million, 2022-2033
- Table 25: Spain Non-Invasive Prenatal Testing Market (by End User), $Million, 2022-2033
- Table 26: Spain Non-Invasive Prenatal Testing Market (by Platform), $Million, 2022-2033
- Table 27: Spain Non-Invasive Prenatal Testing Market (by Method), $Million, 2022-2033
- Table 28: Italy Non-Invasive Prenatal Testing Market (by Application), $Million, 2022-2033
- Table 29: Italy Non-Invasive Prenatal Testing Market (by End User), $Million, 2022-2033
- Table 30: Italy Non-Invasive Prenatal Testing Market (by Platform), $Million, 2022-2033
- Table 31: Italy Non-Invasive Prenatal Testing Market (by Method), $Million, 2022-2033
- Table 32: Rest-of-Europe Non-Invasive Prenatal Testing Market (by Application), $Million, 2022-2033
- Table 33: Rest-of-Europe Non-Invasive Prenatal Testing Market (by End User), $Million, 2022-2033
- Table 34: Rest-of-Europe Non-Invasive Prenatal Testing Market (by Platform), $Million, 2022-2033
- Table 35: Rest-of-Europe Non-Invasive Prenatal Testing Market (by Method), $Million, 2022-2033
- Table 36: Market Share (2022)
